Insider transactions

EDGAR

CAPRICOR THERAPEUTICS, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
13 transactions, 272,529 shares
Sum of shares × price per share: 8,365,886.618

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 69

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-06-25 Filed 2026-06-29Bergmann Anthony Officer: CHIEF FINANCIAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)24,1003.18
76,638

Derived: shares × price per share. Exact value 76638.00.

35,323Direct (D) No— Open filing 0001593087-26-000013 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29Bergmann Anthony Officer: CHIEF FINANCIAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)24,10030.38
732,158

Derived: shares × price per share. Exact value 732158.00.

11,223Direct (D) No
F1, F2
  • F1 Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  • F2 The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.88, inclusive.
Open filing 0001593087-26-000013 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29Bergmann Anthony Officer: CHIEF FINANCIAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (24,100) — exercise price 3.18
Disposed (D)24,1000—91,980Direct (D) No
F3
  • F3 Shares vested 1/48th on the first day of each month commencing February 1, 2022.
Open filing 0001593087-26-000013 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29Krasney Karen Officer: EVP, GENERAL COUNSEL
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)24,1003.18
76,638

Derived: shares × price per share. Exact value 76638.00.

54,647Direct (D) No— Open filing 0001593086-26-000012 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29Krasney Karen Officer: EVP, GENERAL COUNSEL
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)24,10030.38
732,158

Derived: shares × price per share. Exact value 732158.00.

30,547Direct (D) No
F1, F2
  • F1 Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  • F2 The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.88, inclusive.
Open filing 0001593086-26-000012 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29Krasney Karen Officer: EVP, GENERAL COUNSEL
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (24,100) — exercise price 3.18
Disposed (D)24,1000—31,261Direct (D) No
F3
  • F3 Shares vested 1/48th on the first day of each month commencing February 1, 2022.
Open filing 0001593086-26-000012 Read from the filing’s XML Dispute this row
2026-06-24 Filed 2026-06-24Krasney Karen Officer: EVP, GENERAL COUNSEL
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)4003.18
1,272

Derived: shares × price per share. Exact value 1272.00.

30,947Direct (D) No— Open filing 0001593086-26-000010 Read from the filing’s XML Dispute this row
2026-06-24 Filed 2026-06-24Krasney Karen Officer: EVP, GENERAL COUNSEL
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)40030
12,000

Derived: shares × price per share. Exact value 12000.

30,547Direct (D) No
F1
  • F1 Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Open filing 0001593086-26-000010 Read from the filing’s XML Dispute this row
2026-06-24 Filed 2026-06-24Krasney Karen Officer: EVP, GENERAL COUNSEL
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (400) — exercise price 3.18
Disposed (D)4000—55,361Direct (D) No
F2
  • F2 Shares vested 1/48th on the first day of each month commencing February 1, 2022.
Open filing 0001593086-26-000010 Read from the filing’s XML Dispute this row
2026-06-24 Filed 2026-06-24Bergmann Anthony Officer: CHIEF FINANCIAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)4003.18
1,272

Derived: shares × price per share. Exact value 1272.00.

11,623Direct (D) No— Open filing 0001593087-26-000011 Read from the filing’s XML Dispute this row
2026-06-24 Filed 2026-06-24Bergmann Anthony Officer: CHIEF FINANCIAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)40030
12,000

Derived: shares × price per share. Exact value 12000.

11,223Direct (D) No
F1
  • F1 Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Open filing 0001593087-26-000011 Read from the filing’s XML Dispute this row
2026-06-24 Filed 2026-06-24Bergmann Anthony Officer: CHIEF FINANCIAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (400) — exercise price 3.18
Disposed (D)4000—116,080Direct (D) No
F2
  • F2 Shares vested 1/48th on the first day of each month commencing February 1, 2022.
Open filing 0001593087-26-000011 Read from the filing’s XML Dispute this row
2026-06-22 Filed 2026-06-24Krasney Karen Officer: EVP, GENERAL COUNSEL
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)5003.18
1,590

Derived: shares × price per share. Exact value 1590.00.

31,047Direct (D) No— Open filing 0001593086-26-000010 Read from the filing’s XML Dispute this row
2026-06-22 Filed 2026-06-24Krasney Karen Officer: EVP, GENERAL COUNSEL
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)50030
15,000

Derived: shares × price per share. Exact value 15000.

30,547Direct (D) No
F1
  • F1 Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Open filing 0001593086-26-000010 Read from the filing’s XML Dispute this row
2026-06-22 Filed 2026-06-24Krasney Karen Officer: EVP, GENERAL COUNSEL
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (500) — exercise price 3.18
Disposed (D)5000—55,761Direct (D) No
F2
  • F2 Shares vested 1/48th on the first day of each month commencing February 1, 2022.
Open filing 0001593086-26-000010 Read from the filing’s XML Dispute this row
2026-06-22 Filed 2026-06-24Bergmann Anthony Officer: CHIEF FINANCIAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)5003.18
1,590

Derived: shares × price per share. Exact value 1590.00.

11,723Direct (D) No— Open filing 0001593087-26-000011 Read from the filing’s XML Dispute this row
2026-06-22 Filed 2026-06-24Bergmann Anthony Officer: CHIEF FINANCIAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)50030
15,000

Derived: shares × price per share. Exact value 15000.

11,223Direct (D) No
F1
  • F1 Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Open filing 0001593087-26-000011 Read from the filing’s XML Dispute this row
2026-06-22 Filed 2026-06-24Bergmann Anthony Officer: CHIEF FINANCIAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (500) — exercise price 3.18
Disposed (D)5000—116,480Direct (D) No
F2
  • F2 Shares vested 1/48th on the first day of each month commencing February 1, 2022.
Open filing 0001593087-26-000011 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-28Maurer Michael T Officer: CHIEF COMMERCIAL OFFICER
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (80,000) — exercise price 29.36
Acquired (A)80,0000—80,000Direct (D) No
F1
  • F1 The shares vest 25% on the first anniversary of the first day of the month following the Grant Date, with the remainder to vest at the rate of 1/36 per month thereafter. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting.
Open filing 0002137554-26-000006 Read from the filing’s XML Dispute this row
2026-05-18 Filed 2026-05-19Bergmann Anthony Officer: CHIEF FINANCIAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)3,0001.39
4,170

Derived: shares × price per share. Exact value 4170.00.

11,223Direct (D) No— Open filing 0001593087-26-000009 Read from the filing’s XML Dispute this row
2026-05-18 Filed 2026-05-19Bergmann Anthony Officer: CHIEF FINANCIAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (3,000) — exercise price 1.39
Disposed (D)3,0000—0Direct (D) No
F1, F2
  • F1 This option was granted on June 2, 2016 and was previously reported as covering 30,000 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020.
  • F2 Shares vested 1/48th on the first day of each month commencing as of July 1, 2016.
Open filing 0001593087-26-000009 Read from the filing’s XML Dispute this row
2026-05-13 Filed 2026-05-14Litvack Frank Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)3,9371.39
5,472.43

Derived: shares × price per share. Exact value 5472.43.

133,776Direct (D) No— Open filing 0001310715-26-000004 Read from the filing’s XML Dispute this row
2026-05-13 Filed 2026-05-14Litvack Frank Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (3,937) — exercise price 1.39
Disposed (D)3,9370—0Direct (D) No
F2, F3
  • F2 This option was granted on June 2, 2016 and was previously reported as covering 39,375 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020.
  • F3 1,750 shares vested immediately on June 2, 2016. The remaining shares vested on December 31, 2016.
Open filing 0001310715-26-000004 Read from the filing’s XML Dispute this row
2026-05-01 Filed 2026-05-04Bergmann Anthony Officer: CHIEF FINANCIAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)25,0003.18
79,500

Derived: shares × price per share. Exact value 79500.00.

33,223Direct (D) Yes— Open filing 0001593087-26-000007 Read from the filing’s XML Dispute this row
2026-05-01 Filed 2026-05-04Bergmann Anthony Officer: CHIEF FINANCIAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)25,00031.7016
792,540

Derived: shares × price per share. Exact value 792540.0000.

8,223Direct (D) Yes
F1, F2
  • F1 Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  • F2 The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.89 to $33.19, inclusive.
Open filing 0001593087-26-000007 Read from the filing’s XML Dispute this row
2026-05-01 Filed 2026-05-04Bergmann Anthony Officer: CHIEF FINANCIAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (25,000) — exercise price 3.18
Disposed (D)25,0000—116,980Direct (D) Yes
F3
  • F3 Shares vested 1/48th on the first day of each month commencing February 1, 2022.
Open filing 0001593087-26-000007 Read from the filing’s XML Dispute this row
2026-05-01 Filed 2026-05-04Krasney Karen Officer: EVP, GENERAL COUNSEL
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)25,0003.18
79,500

Derived: shares × price per share. Exact value 79500.00.

55,547Direct (D) Yes— Open filing 0001593086-26-000008 Read from the filing’s XML Dispute this row
2026-05-01 Filed 2026-05-04Krasney Karen Officer: EVP, GENERAL COUNSEL
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)25,00031.7019
792,547.5

Derived: shares × price per share. Exact value 792547.5000.

30,547Direct (D) Yes
F1, F2
  • F1 Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  • F2 The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.88 to $33.19, inclusive.
Open filing 0001593086-26-000008 Read from the filing’s XML Dispute this row
2026-05-01 Filed 2026-05-04Krasney Karen Officer: EVP, GENERAL COUNSEL
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (25,000) — exercise price 3.18
Disposed (D)25,0000—56,261Direct (D) Yes
F3
  • F3 Shares vested 1/48th on the first day of each month commencing February 1, 2022.
Open filing 0001593086-26-000008 Read from the filing’s XML Dispute this row
2026-04-02 Filed 2026-04-03Sabar Karimah Es Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)7,5293.18
23,942.22

Derived: shares × price per share. Exact value 23942.22.

7,529Direct (D) Yes— Open filing 0001873796-26-000006 Read from the filing’s XML Dispute this row
2026-04-02 Filed 2026-04-03Sabar Karimah Es Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,52932
240,928

Derived: shares × price per share. Exact value 240928.

0Direct (D) Yes
F1
  • F1 Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Open filing 0001873796-26-000006 Read from the filing’s XML Dispute this row
2026-04-02 Filed 2026-04-03Sabar Karimah Es Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (7,529) — exercise price 3.18
Disposed (D)7,5290—161Direct (D) Yes
F2
  • F2 Shares vested 1/48th on the first day of each month commencing February 1, 2022.
Open filing 0001873796-26-000006 Read from the filing’s XML Dispute this row
2026-04-01 Filed 2026-04-01Sabar Karimah Es Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)53,7354.86
261,152.1

Derived: shares × price per share. Exact value 261152.10.

53,735Direct (D) Yes— Open filing 0001873796-26-000004 Read from the filing’s XML Dispute this row
2026-04-01 Filed 2026-04-01Sabar Karimah Es Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)53,73531.0268
1,667,225.098

Derived: shares × price per share. Exact value 1667225.0980.

0Direct (D) Yes
F1, F3
  • F1 Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  • F3 The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.28 to $31.39, inclusive.
Open filing 0001873796-26-000004 Read from the filing’s XML Dispute this row
2026-04-01 Filed 2026-04-01Sabar Karimah Es Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (53,735) — exercise price 4.86
Disposed (D)53,7350—0Direct (D) Yes
F4
  • F4 Shares vested 25% on August 1, 2022 with the remainder vesting 1/36 per month commencing September 1, 2022.
Open filing 0001873796-26-000004 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-04-01Sabar Karimah Es Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)61,2654.86
297,747.9

Derived: shares × price per share. Exact value 297747.90.

61,265Direct (D) Yes— Open filing 0001873796-26-000004 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-04-01Sabar Karimah Es Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)61,26530.168
1,848,242.52

Derived: shares × price per share. Exact value 1848242.520.

0Direct (D) Yes
F1, F2
  • F1 Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  • F2 The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.46, inclusive.
Open filing 0001873796-26-000004 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-04-01Sabar Karimah Es Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (61,265) — exercise price 4.86
Disposed (D)61,2650—53,735Direct (D) Yes
F4
  • F4 Shares vested 25% on August 1, 2022 with the remainder vesting 1/36 per month commencing September 1, 2022.
Open filing 0001873796-26-000004 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-04-01Bergmann Anthony Officer: CHIEF FINANCIAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)25,0003.18
79,500

Derived: shares × price per share. Exact value 79500.00.

33,223Direct (D) Yes— Open filing 0001593087-26-000005 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-04-01Bergmann Anthony Officer: CHIEF FINANCIAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)25,00030.1261
753,152.5

Derived: shares × price per share. Exact value 753152.5000.

8,223Direct (D) Yes
F1, F2
  • F1 Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  • F2 The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.32, inclusive.
Open filing 0001593087-26-000005 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-04-01Bergmann Anthony Officer: CHIEF FINANCIAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (25,000) — exercise price 3.18
Disposed (D)25,0000—141,980Direct (D) Yes
F3
  • F3 Shares vested 1/48th on the first day of each month commencing February 1, 2022.
Open filing 0001593087-26-000005 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-04-01Krasney Karen Officer: EVP, GENERAL COUNSEL
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)6931.39
963.27

Derived: shares × price per share. Exact value 963.27.

31,240Direct (D) Yes— Open filing 0001593086-26-000006 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-04-01Krasney Karen Officer: EVP, GENERAL COUNSEL
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)21,4883.74
80,365.12

Derived: shares × price per share. Exact value 80365.12.

52,728Direct (D) Yes— Open filing 0001593086-26-000006 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-04-01Krasney Karen Officer: EVP, GENERAL COUNSEL
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)2,8193.18
8,964.42

Derived: shares × price per share. Exact value 8964.42.

55,547Direct (D) Yes— Open filing 0001593086-26-000006 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-04-01Krasney Karen Officer: EVP, GENERAL COUNSEL
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)25,00030.1174
752,935

Derived: shares × price per share. Exact value 752935.0000.

30,547Direct (D) Yes
F1, F2
  • F1 Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  • F2 The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.31, inclusive.
Open filing 0001593086-26-000006 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-04-01Krasney Karen Officer: EVP, GENERAL COUNSEL
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (693) — exercise price 1.39
Disposed (D)6930—2,807Direct (D) Yes
F3, F4
  • F3 This option was granted on January 2, 2018 and was previously reported as covering 35,000 shares at an exercise price of $1.57 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020.
  • F4 Shares vested 1/48th on the first day of each month commencing February 1, 2018.
Open filing 0001593086-26-000006 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-04-01Krasney Karen Officer: EVP, GENERAL COUNSEL
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (21,488) — exercise price 3.74
Disposed (D)21,4880—74,205Direct (D) Yes
F5
  • F5 Shares vested 1/48th on the first day of each month commencing February 1, 2021.
Open filing 0001593086-26-000006 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-04-01Krasney Karen Officer: EVP, GENERAL COUNSEL
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (2,819) — exercise price 3.18
Disposed (D)2,8190—81,261Direct (D) Yes
F6
  • F6 Shares vested 1/48th on the first day of each month commencing February 1, 2022.
Open filing 0001593086-26-000006 Read from the filing’s XML Dispute this row
2026-01-05 Filed 2026-01-07Krasney Karen Officer: EVP, GENERAL COUNSEL
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (22,500) — exercise price 24.81
Acquired (A)22,5000—22,500Direct (D) No
F1
  • F1 The shares vest 1/48th of the first day of each month, commencing February 1, 2026, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting.
Open filing 0001593086-26-000002 Read from the filing’s XML Dispute this row
2026-01-05 Filed 2026-01-07Krasney Karen Officer: EVP, GENERAL COUNSEL
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (22,500) — exercise price 24.81
Acquired (A)22,5000—22,500Direct (D) No
F2
  • F2 These shares of the award vest and become exercisable on the date of U.S. Food and Drug Administration approval of Deramiocel. Vesting is subject to the Reporting Person's continued service to the Issuer through the vesting date.
Open filing 0001593086-26-000002 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–50 of 185

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
BlackRock, Inc. Partly reported under another manager4,178,205 SH39,567,603 dollarsHigher by 33,144 Prior quarter: 4,145,061Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
STATE STREET CORP Partly reported under another manager3,019,025 SH28,590,167 dollarsLower by 378,125 Prior quarter: 3,397,150Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
RA CAPITAL MANAGEMENT, L.P. 3,014,183 SH28,544,313 dollarsHigher by 1,506,339 Prior quarter: 1,507,844Open filing 0001104659-26-128411 Filed 2026-11-16 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 2,303,381 SH21,813,018 dollarsHigher by 5,707 Prior quarter: 2,297,674Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
D. E. Shaw Co., Inc. Partly reported under another manager2,141,641 SH20,281,340 dollarsHigher by 2,017,895 Prior quarter: 123,746Open filing 0001104659-26-128287 Filed 2026-11-16 Dispute this row
MILLENNIUM MANAGEMENT LLC 1,669,083 SH15,806,216 dollarsHigher by 1,435,157 Prior quarter: 233,926Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
CITADEL ADVISORS LLC Option: Call Partly reported under another manager1,429,100 SH13,533,577 dollarsHigher by 955,900 Prior quarter: 473,200Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
UBS Group AG Partly reported under another manager1,403,356 SH13,289,781 dollarsHigher by 783,695 Prior quarter: 619,661Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Put Partly reported under another manager1,400,100 SH13,258,947 dollarsHigher by 872,100 Prior quarter: 528,000Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
EcoR1 Capital, LLC 1,376,580 SH13,036,213 dollarsNot in the prior quarter’s filings read Open filing 0000935836-26-000577 Filed 2026-11-16 Dispute this row
Longaeva Partners L.P. Partly reported under another manager1,231,841 SH11,665,534 dollarsHigher by 1,157,795 Prior quarter: 74,046Open filing 0001193125-26-463222 Filed 2026-11-16 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager1,137,681 SH10,775,852 dollarsLower by 234,605 Prior quarter: 1,372,286Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
CITADEL ADVISORS LLC Option: Put Partly reported under another manager1,036,900 SH9,819,443 dollarsHigher by 778,500 Prior quarter: 258,400Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager974,300 SH9,226,621 dollarsLower by 90,400 Prior quarter: 1,064,700Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
TWO SIGMA INVESTMENTS, LP 946,870 SH8,966,859 dollarsNot in the prior quarter’s filings read Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row
Jones Hill Capital LP 892,532 SH8,452,278 dollarsHigher by 471,781 Prior quarter: 420,751Open filing 0002102314-26-000006 Filed 2026-11-13 Dispute this row
PERCEPTIVE ADVISORS LLC 850,000 SH8,049,500 dollarsNot in the prior quarter’s filings read Open filing 0001012975-26-001063 Filed 2026-11-16 Dispute this row
Balyasny Asset Management L.P. 812,718 SH7,696,439 dollarsHigher by 325,882 Prior quarter: 486,836Open filing 0001193125-26-463223 Filed 2026-11-16 Dispute this row
MERCER GLOBAL ADVISORS INC /ADV Partly reported under another manager808,610 SH7,657,536 dollarsHigher by 5,878 Prior quarter: 802,732Open filing 0000853758-26-000020 Filed 2026-11-16 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager700,431 SH6,633,082 dollarsHigher by 690,969 Prior quarter: 9,462Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
Soleus Capital Management, L.P. 699,149 SH6,620,941 dollarsLower by 62,588 Prior quarter: 761,737Open filing 0001802630-26-000008 Filed 2026-11-16 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager697,355 SH6,603,952 dollarsLower by 880,776 Prior quarter: 1,578,131Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
Point72 Asset Management, L.P. 671,505 SH6,359,152 dollarsHigher by 576,782 Prior quarter: 94,723Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row
Boxer Capital Management, LLC 642,837 SH6,087,666 dollarsLower by 752,319 Prior quarter: 1,395,156Open filing 0001213900-26-120704 Filed 2026-11-16 Dispute this row
Palo Alto Investors LP 548,071 SH5,190,232 dollarsHigher by 318,308 Prior quarter: 229,763Open filing 0002073679-26-000180 Filed 2026-11-16 Dispute this row
ADAR1 Capital Management, LLC 526,996 SH4,990,652 dollarsHigher by 436,403 Prior quarter: 90,593Open filing 0001940272-26-000033 Filed 2026-11-16 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 517,260 SH4,898,452 dollarsLower by 118,827 Prior quarter: 636,087Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager508,100 SH4,811,706 dollarsHigher by 4,568 Prior quarter: 503,532Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
DIADEMA PARTNERS LP Option: Call 497,300 SH4,709,431 dollarsHigher by 168,000 Prior quarter: 329,300Open filing 0001892688-26-000170 Filed 2026-11-16 Dispute this row
DIADEMA PARTNERS LP Option: Put 484,400 SH4,587,268 dollarsLower by 50,000 Prior quarter: 534,400Open filing 0001892688-26-000170 Filed 2026-11-16 Dispute this row
Jump Financial, LLC Partly reported under another manager480,286 SH4,548,308 dollarsHigher by 457,250 Prior quarter: 23,036Open filing 0000905148-26-004786 Filed 2026-11-13 Dispute this row
NATIONAL BANK OF CANADA /FI/ 399,300 SH3,781,371 dollarsHigher by 399,289 Prior quarter: 11Open filing 0000926171-26-000014 Filed 2026-11-16 Dispute this row
VANGUARD FIDUCIARY TRUST CO 379,254 SH3,591,535 dollarsHigher by 6,715 Prior quarter: 372,539Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
MORGAN STANLEY Partly reported under another manager377,740 SH3,577,201 dollarsLower by 306,775 Prior quarter: 684,515Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
GROUP ONE TRADING LLC Option: Call 372,800 SH3,530,416 dollarsHigher by 273,800 Prior quarter: 99,000Open filing 0000932540-26-000017 Filed 2026-11-10 Dispute this row
CITIGROUP INC Partly reported under another manager360,665 SH3,415,498 dollarsHigher by 280,542 Prior quarter: 80,123Open filing 0000831001-26-000052 Filed 2026-11-04 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager339,771 SH2,936,913 dollarsLower by 22,730 Prior quarter: 362,501Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
Caption Management, LLC Option: Call 323,100 SH3,059,757 dollarsLower by 125,500 Prior quarter: 448,600Open filing 0001706766-26-000008 Filed 2026-11-16 Dispute this row
D. E. Shaw Co., Inc. Option: Call Partly reported under another manager315,000 SH2,983,050 dollarsUnchanged Prior quarter: 315,000Open filing 0001104659-26-128287 Filed 2026-11-16 Dispute this row
SIMPLEX TRADING, LLC Option: Call 288,000 SH2,727,360 dollarsHigher by 193,500 Prior quarter: 94,500Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
DG Capital Management, LLC 279,558 SH2,647,414 dollarsLower by 332,037 Prior quarter: 611,595Open filing 0001512716-26-000017 Filed 2026-11-12 Dispute this row
BARCLAYS PLC Partly reported under another manager275,957 SH2,613,312 dollarsHigher by 208,517 Prior quarter: 67,440Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
RTW INVESTMENTS, LP 250,000 SH2,367,500 dollarsUnchanged Prior quarter: 250,000Open filing 0001493215-26-000214 Filed 2026-11-16 Dispute this row
Quantinno Capital Management LP 248,285 SH2,351,259 dollarsHigher by 233,444 Prior quarter: 14,841Open filing 0001759654-26-000011 Filed 2026-11-13 Dispute this row
SIMPLEX TRADING, LLC Option: Put 245,400 SH2,323,938 dollarsHigher by 181,900 Prior quarter: 63,500Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
Squarepoint Ops LLC Partly reported under another manager238,892 SH2,262,307 dollarsHigher by 219,161 Prior quarter: 19,731Open filing 0001642575-26-000012 Filed 2026-11-09 Dispute this row
Ikarian Capital, LLC 229,215 SH2,170,666 dollarsLower by 375,000 Prior quarter: 604,215Open filing 0001420506-26-002881 Filed 2026-11-16 Dispute this row
HBK Sorce Advisory LLC Partly reported under another manager225,256 SH1,937,202 dollarsHigher by 2,180 Prior quarter: 223,076Open filing 0001379995-26-000006 Filed 2026-11-06 Dispute this row
CANTOR FITZGERALD, L. P. Partly reported under another manager225,000 SH2,130,750 dollarsNot in the prior quarter’s filings read Open filing 0000929638-26-004323 Filed 2026-11-16 Dispute this row
Nuveen, LLC Partly reported under another manager210,651 SH1,994,866 dollarsLower by 25,961 Prior quarter: 236,612Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • TANG CAPITAL MANAGEMENT LLC 4,099,900 SH
  • MONTANOVA CAPITAL, LLC 4,092,784 SH
  • PERCEPTIVE ADVISORS LLC 1,000,000 SH
  • PERCEPTIVE ADVISORS LLC 500,000 SH
  • J. Goldman Co LP 427,321 SH
  • Ikarian Capital, LLC 350,000 SH
  • Moody Aldrich Partners LLC 177,754 SH
  • Sixth Street Partners Management Company, L.P. 160,938 SH
  • MILLENNIUM MANAGEMENT LLC 125,000 SH
  • PFM Health Sciences, LP 122,221 SH
  • Pier Capital, LLC 111,908 SH
  • BOOTHBAY FUND MANAGEMENT, LLC 105,900 SH
  • Jefferies Financial Group Inc. 105,755 SH
  • WELLINGTON MANAGEMENT GROUP LLP 100,246 SH
  • MARSHALL WACE, LLP 98,185 SH
  • Curated Wealth Partners LLC 50,000 SH
  • Quinn Opportunity Partners LLC 44,698 SH
  • FRANKLIN RESOURCES INC 43,568 SH
  • MILLENNIUM MANAGEMENT LLC 43,300 SH
  • GLENMEDE TRUST CO NA 39,935 SH
  • CITIGROUP INC 31,500 SH
  • ENVESTNET ASSET MANAGEMENT INC 29,058 SH
  • TWINBEECH CAPITAL LP 28,337 SH
  • Aquatic Capital Management LLC 26,257 SH
  • SEVEN GRAND MANAGERS, LLC 25,000 SH
  • Anson Funds Management LP 25,000 SH
  • Jupiter Topco LLC 22,600 SH
  • XTX Topco Ltd 21,993 SH
  • SEI INVESTMENTS CO 17,385 SH
  • INTECH INVESTMENT MANAGEMENT LLC 17,114 SH
  • TUDOR INVESTMENT CORP ET AL 15,816 SH
  • Birchview Capital, LP 14,352 SH
  • nVerses Capital, LLC 13,951 SH
  • OneDigital Investment Advisors LLC 11,384 SH
  • SG Americas Securities, LLC 10,604 SH
  • MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 10,095 SH
  • DLD Asset Management, LP 10,000 SH
  • Orion Porfolio Solutions, LLC 9,746 SH
  • Arrowpoint Investment Partners (Singapore) Pte. Ltd. 9,342 SH
  • STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 9,239 SH
  • DeepCurrents Investment Group LLC 9,045 SH
  • AQR CAPITAL MANAGEMENT LLC 8,948 SH
  • PRUDENTIAL FINANCIAL INC 8,760 SH
  • E Fund Management Co., Ltd. 8,513 SH
  • Ensign Peak Advisors, Inc 3,100 SH
  • China Universal Asset Management Co., Ltd. 1,600 SH
  • KBC Group NV 1,461 SH
  • State of Wyoming 1,252 SH
  • Pacer Advisors, Inc. 1,008 SH
  • Integrated Wealth Concepts LLC 756 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

Showing 1–2 of 2

House members’ trades in this company, newest report first, as filed
MemberTransaction dateTypeAmountOwnerReport
Hon. Roger W. Marshall (KS01)2017-07-27Purchase$1,001 - $15,000DC2018-08-06
Hon. Roger W. Marshall (KS01)2017-07-27Sale$1,001 - $15,000DC2018-08-06

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
TANG CAPITAL MANAGEMENT, LLC Common Stock, par value $0.001 per share00.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 2Open filing 0001214659-26-014413 Dispute this row
KEVIN TANG Common Stock, par value $0.001 per share00.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 2Open filing 0001214659-26-014413 Dispute this row
TANG CAPITAL PARTNERS, LP Common Stock, par value $0.001 per share00.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 2Open filing 0001214659-26-014413 Dispute this row
TANG CAPITAL PARTNERS INTERNATIONAL, LP Common Stock, par value $0.001 per share00.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 2Open filing 0001214659-26-014413 Dispute this row
TANG CAPITAL PARTNERS III, INC Common Stock, par value $0.001 per share00.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 2Open filing 0001214659-26-014413 Dispute this row
TANG CAPITAL PARTNERS IV, INC Common Stock, par value $0.001 per share00.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 2Open filing 0001214659-26-014413 Dispute this row
Montanova Capital, LLC Common Stock, par value $0.001 per share00.0009/30/2026 Filed 2026-11-13SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-007761 Dispute this row
Averill Master Fund, Ltd. Common Stock, par value $0.001 per share00.0009/30/2026 Filed 2026-11-13SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-007761 Dispute this row
Aaron Cowen Common Stock, par value $0.001 per share00.0009/30/2026 Filed 2026-11-13SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-007761 Dispute this row
Millennium Management LLC Common Stock, par value $0.001 per share2.91,669,083.0009/30/2026 Filed 2026-10-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-115876 Dispute this row
Millennium Group Management LLC Common Stock, par value $0.001 per share2.91,669,083.0009/30/2026 Filed 2026-10-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-115876 Dispute this row
Israel A. Englander Common Stock, par value $0.001 per share2.91,669,083.0009/30/2026 Filed 2026-10-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-115876 Dispute this row
Millennium Management LLC Common Stock, par value $0.001 per share5.12,943,086.0009/08/2026 Filed 2026-09-14SCHEDULE 13GOpen filing 0001104659-26-107591 Dispute this row
Millennium Group Management LLC Common Stock, par value $0.001 per share5.12,943,086.0009/08/2026 Filed 2026-09-14SCHEDULE 13GOpen filing 0001104659-26-107591 Dispute this row
Israel A. Englander Common Stock, par value $0.001 per share5.12,943,086.0009/08/2026 Filed 2026-09-14SCHEDULE 13GOpen filing 0001104659-26-107591 Dispute this row
Millennium Management LLC Common Stock, par value $0.001 per share4.92,857,387.0008/17/2026 Filed 2026-08-19SCHEDULE 13GOpen filing 0001104659-26-098872 Dispute this row
Millennium Group Management LLC Common Stock, par value $0.001 per share4.92,857,387.0008/17/2026 Filed 2026-08-19SCHEDULE 13GOpen filing 0001104659-26-098872 Dispute this row
Israel A. Englander Common Stock, par value $0.001 per share4.92,857,387.0008/17/2026 Filed 2026-08-19SCHEDULE 13GOpen filing 0001104659-26-098872 Dispute this row
RA Capital Management, L.P. Common Stock, $0.001 par value per share5.23,014,183.0007/27/2026 Filed 2026-08-03SCHEDULE 13GOpen filing 0001346824-26-000208 Dispute this row
Peter Kolchinsky Common Stock, $0.001 par value per share5.23,014,183.0007/27/2026 Filed 2026-08-03SCHEDULE 13GOpen filing 0001346824-26-000208 Dispute this row
Rajeev Shah Common Stock, $0.001 par value per share5.23,014,183.0007/27/2026 Filed 2026-08-03SCHEDULE 13GOpen filing 0001346824-26-000208 Dispute this row
RA Capital Healthcare Fund, L.P. Common Stock, $0.001 par value per share5.23,014,183.0007/27/2026 Filed 2026-08-03SCHEDULE 13GOpen filing 0001346824-26-000208 Dispute this row
TANG CAPITAL MANAGEMENT, LLC Common Stock, par value $0.001 per share7.14,099,900.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-26-010417 Dispute this row
KEVIN TANG Common Stock, par value $0.001 per share7.14,099,900.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-26-010417 Dispute this row
TANG CAPITAL PARTNERS, LP Common Stock, par value $0.001 per share1.6923,783.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-26-010417 Dispute this row
TANG CAPITAL PARTNERS INTERNATIONAL, LP Common Stock, par value $0.001 per share2.21,281,251.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-26-010417 Dispute this row
TANG CAPITAL PARTNERS III, INC Common Stock, par value $0.001 per share1.5877,133.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-26-010417 Dispute this row
TANG CAPITAL PARTNERS IV, INC Common Stock, par value $0.001 per share1.81,017,733.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-26-010417 Dispute this row
STATE STREET CORPORATION COMMON STOCK5.93,397,241.0006/30/2026 Filed 2026-08-07SCHEDULE 13GOpen filing 0000093751-26-000426 Dispute this row
SUVRETTA CAPITAL MANAGEMENT, LLC Common Stock, par value $0.001 per share6.63,417,891.0002/19/2026 Filed 2026-02-26SCHEDULE 13GOpen filing 0000919574-26-001397 Dispute this row
Averill Master Fund, Ltd. Common Stock, par value $0.001 per share5.62,917,420.0002/19/2026 Filed 2026-02-26SCHEDULE 13GOpen filing 0000919574-26-001397 Dispute this row
Aaron Cowen Common Stock, par value $0.001 per share6.63,417,891.0002/19/2026 Filed 2026-02-26SCHEDULE 13GOpen filing 0000919574-26-001397 Dispute this row
TANG CAPITAL MANAGEMENT, LLC Common Stock, par value $0.001 per share6.63,399,900.0001/16/2026 Filed 2026-01-26SCHEDULE 13GOpen filing 0001214659-26-000831 Dispute this row
KEVIN TANG Common Stock, par value $0.001 per share6.63,399,900.0001/16/2026 Filed 2026-01-26SCHEDULE 13GOpen filing 0001214659-26-000831 Dispute this row
TANG CAPITAL PARTNERS, LP Common Stock, par value $0.001 per share4.52,337,350.0001/16/2026 Filed 2026-01-26SCHEDULE 13GOpen filing 0001214659-26-000831 Dispute this row
TANG CAPITAL PARTNERS INTERNATIONAL, LP Common Stock, par value $0.001 per share2.11,062,550.0001/16/2026 Filed 2026-01-26SCHEDULE 13GOpen filing 0001214659-26-000831 Dispute this row
TANG CAPITAL PARTNERS III, INC Common Stock, par value $0.001 per share0.00.0001/16/2026 Filed 2026-01-26SCHEDULE 13GOpen filing 0001214659-26-000831 Dispute this row
TANG CAPITAL PARTNERS IV, INC Common Stock, par value $0.001 per share0.00.0001/16/2026 Filed 2026-01-26SCHEDULE 13GOpen filing 0001214659-26-000831 Dispute this row
Highbridge Capital Management, LLC Common Stock, par value $0.001 per share2.31,200,000.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 2Open filing 0000902664-26-001091 Dispute this row
The Vanguard Group Common Stock4.822,206,71909/30/2025 Filed 2025-10-30SCHEDULE 13G/AAmendment 1Open filing 0000102909-25-000120 Dispute this row
The Vanguard Group Common Stock5.042,305,07806/30/2025 Filed 2025-07-29SCHEDULE 13GOpen filing 0000932471-25-000799 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,686,536 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015103,592
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,154

Filings made before the SEC required XML are listed, not extracted.

Back to CAPRICOR THERAPEUTICS, INC.